A new approach to designing phase I-II cancer trials for cytotoxic chemotherapies.

Abstract:

:Recently, there has been much work on early phase cancer designs that incorporate both toxicity and efficacy data, called phase I-II designs because they combine elements of both phases. However, they do not explicitly address the phase II hypothesis test of H0 : p ≤ p0 , where p is the probability of efficacy at the estimated maximum tolerated dose η from phase I and p0 is the baseline efficacy rate. Standard practice for phase II remains to treat p as a fixed, unknown parameter and to use Simon's two-stage design with all patients dosed at η. We propose a phase I-II design that addresses the uncertainty in the estimate p=p(η) in H0 by using sequential generalized likelihood theory. Combining this with a phase I design that incorporates efficacy data, the phase I-II design provides a common framework that can be used all the way from the first dose of phase I through the final accept/reject decision about H0 at the end of phase II, utilizing both toxicity and efficacy data throughout. Efficient group sequential testing is used in phase II that allows for early stopping to show treatment effect or futility. The proposed phase I-II design thus removes the artificial barrier between phase I and phase II and fulfills the objectives of searching for the maximum tolerated dose and testing if the treatment has an acceptable response rate to enter into a phase III trial.

journal_name

Stat Med

journal_title

Statistics in medicine

authors

Bartroff J,Lai TL,Narasimhan B

doi

10.1002/sim.6124

subject

Has Abstract

pub_date

2014-07-20 00:00:00

pages

2718-35

issue

16

eissn

0277-6715

issn

1097-0258

journal_volume

33

pub_type

杂志文章
  • Reflecting on "A Statistician in Medicine" in 2020.

    abstract::In this commentary, we revisit Sir Austin Bradford Hill's seminal Alfred Watson Memorial Lecture in 1962 through the eyes of two practicing biostatisticians of the current era. We summarize some eternal takeaway messages from Hill's lecture regarding observations and experiments translated through the modern lexicon o...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.8830

    authors: Dempsey W,Mukherjee B

    更新日期:2021-01-15 00:00:00

  • The Peto odds ratio viewed as a new effect measure.

    abstract::Meta-analysis has generally been accepted as a fundamental tool for combining effect estimates from several studies. For binary studies with rare events, the Peto odds ratio (POR) method has become the relative effect estimator of choice. However, the POR leads to biased estimates for the OR when treatment effects are...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.6301

    authors: Brockhaus AC,Bender R,Skipka G

    更新日期:2014-12-10 00:00:00

  • Multilocus linkage disequilibrium mapping of epistatic quantitative trait loci that regulate HIV dynamics: a simulation approach.

    abstract::The time-dependent change of HIV particle load, i.e. HIV dynamics, is likely to be controlled by a multitude of quantitative trait loci (QTL) that interact with each other as well as with various developmental and environmental factors in a coordinated manner. In this article, we have derived a new statistical model f...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.2489

    authors: Wu S,Yang J,Wu R

    更新日期:2006-11-30 00:00:00

  • Group sequential designs for cure rate models with early stopping in favour of the null hypothesis.

    abstract::Ewell and Ibrahim derived the large sample distribution of the logrank statistic under general local alternatives. Their asymptotic results enable us to extend several group sequential designs which allow for early stopping in favour of the null hypothesis to the setting in which the cure rate model is appropriate. In...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/1097-0258(20001130)19:22<3023::aid-sim638>

    authors: Patricia Bernardo MV,Ibrahim JG

    更新日期:2000-11-30 00:00:00

  • Commentary: How the debate about comparative effectiveness research should impact the future of clinical trials.

    abstract::Comparative effectiveness research represents the kind of research that arguably more directly affects clinical practice and policy. It includes observational studies, clinical trials, and systematic syntheses of existing literature. In this commentary, I argue for the ongoing and critical role of randomization in com...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.5400

    authors: Lauer MS

    更新日期:2012-11-10 00:00:00

  • Common sense and figures: the rhetoric of validity in medicine (Bradford Hill Memorial Lecture 1999).

    abstract::Austin Bradford Hill was once a friend to The Lancet, but, as occasionally happens, friends fall out. The great legacy of his association with the journal, however, was Principles of Medical Statistics. As each edition was succeeded by another--the first in 1937, the last in 1991--he seemed to shift his view about the...

    journal_title:Statistics in medicine

    pub_type:

    doi:10.1002/1097-0258(20001215)19:23<3149::aid-sim617>

    authors: Horton R

    更新日期:2000-12-15 00:00:00

  • Designing a pilot sequential multiple assignment randomized trial for developing an adaptive treatment strategy.

    abstract::There is growing interest in how best to adapt and readapt treatments to individuals to maximize clinical benefit. In response, adaptive treatment strategies (ATS), which operationalize adaptive, sequential clinical decision making, have been developed. From a patient's perspective an ATS is a sequence of treatments, ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4512

    authors: Almirall D,Compton SN,Gunlicks-Stoessel M,Duan N,Murphy SA

    更新日期:2012-07-30 00:00:00

  • Conflicts of interest in data monitoring of industry versus publicly financed clinical trials.

    abstract::The FDA Guidance, while highly appropriate for industry sponsored trials, need not be imposed on publicly (e.g. NIH) financed clinical trials. While the potential for conflicts of interest exist in the latter, they are in general manageable and pose an acceptable low risk of threatening the integrity of a study. Howev...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.1787

    authors: Lachin JM

    更新日期:2004-05-30 00:00:00

  • Long-term survivor mixture model with random effects: application to a multi-centre clinical trial of carcinoma.

    abstract::A mixture model incorporating long-term survivors has been adopted in the field of biostatistics where some individuals may never experience the failure event under study. The surviving fractions may be considered as cured. In most applications, the survival times are assumed to be independent. However, when the survi...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.932

    authors: Yau KK,Ng AS

    更新日期:2001-06-15 00:00:00

  • The relative importance of prognostic factors in studies of survival.

    abstract::The relative importance of prognostic factors in regression can be measured either by standardized regression coefficients or by percentages of explained variation in a dependent variable. One advantage of using explained variation is the direct comparability of qualitative prognostic factors with others, or of groups...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780122413

    authors: Schemper M

    更新日期:1993-12-30 00:00:00

  • Assessing heterogeneity and correlation of paired failure times with the bivariate frailty model.

    abstract::We consider bivariate survival times for heterogeneous populations, where heterogeneity induces deviations in an individual's risk of an event as well as associations between survival times. The heterogeneity is characterized by a bivariate frailty model. We measure the heterogeneity effects through deviations associa...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0258(19990430)18:8<907::aid-sim

    authors: Xue X,Ding Y

    更新日期:1999-04-30 00:00:00

  • The effect of salvage therapy on survival in a longitudinal study with treatment by indication.

    abstract::We consider using observational data to estimate the effect of a treatment on disease recurrence, when the decision to initiate treatment is based on longitudinal factors associated with the risk of recurrence. The effect of salvage androgen deprivation therapy (SADT) on the risk of recurrence of prostate cancer is in...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4017

    authors: Kennedy EH,Taylor JM,Schaubel DE,Williams S

    更新日期:2010-11-10 00:00:00

  • Decomposition of number of life years lost according to causes of death.

    abstract::We study the competing risks model and show that the cause j cumulative incidence function integrated from 0 to τ has a natural interpretation as the expected number of life years lost due to cause j before time τ. This is analogous to the τ-restricted mean lifetime, which is the survival function integrated from 0 to...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.5903

    authors: Andersen PK

    更新日期:2013-12-30 00:00:00

  • Survival analyses of randomized clinical trials adjusted for patients who switch treatments.

    abstract::Patients who switch treatment groups in randomized clinical trials can cause problems in the interpretation of the results. Although the intention-to-treat method is recognized as being the most reliable analysis, it may result in an underestimate of the treatment effect if there have been patients who switch treatmen...

    journal_title:Statistics in medicine

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/(SICI)1097-0258(19961015)15:19<2069::AID-S

    authors: Law MG,Kaldor JM

    更新日期:1996-10-15 00:00:00

  • Effects and non-effects of paired identical observations in comparing proportions with binary matched-pairs data.

    abstract::Binary matched-pairs data occur commonly in longitudinal studies, such as in cross-over experiments. Many analyses for comparing the matched probabilities of a particular outcome do not utilize pairs having the same outcome for each observation. An example is McNemar's test. Some methodologists find this to be counter...

    journal_title:Statistics in medicine

    pub_type: 杂志文章,评审

    doi:10.1002/sim.1589

    authors: Agresti A,Min Y

    更新日期:2004-01-15 00:00:00

  • Simple models for repeated ordinal responses with an application to a seasonal rhinitis clinical trial.

    abstract::In contrast to other models for ordinal data, the continuation ratio model can be fitted with standard statistical software. This makes it particularly appropriate for large clinical trials with ordinal response variables. In addition, when the trials are longitudinal, this model can be applied to individual responses...

    journal_title:Statistics in medicine

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/(sici)1097-0258(19971230)16:24<2873::aid-s

    authors: Lindsey JK,Jones B,Ebbutt AF

    更新日期:1997-12-30 00:00:00

  • Individualizing drug dosage with longitudinal data.

    abstract::We propose a two-step procedure to personalize drug dosage over time under the framework of a log-linear mixed-effect model. We model patients' heterogeneity using subject-specific random effects, which are treated as the realizations of an unspecified stochastic process. We extend the conditional quadratic inference ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.7016

    authors: Zhu X,Qu A

    更新日期:2016-10-30 00:00:00

  • A Bayesian approach estimating treatment effects on biomarkers containing zeros with detection limits.

    abstract::Often in randomized clinical trials and observational studies in occupational and environmental health, a non-negative continuously distributed response variable denoting some metabolites of environmental toxicants is measured in treatment and control groups. When observations occur in both unexposed and exposed subje...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3170

    authors: Chu H,Nie L,Kensler TW

    更新日期:2008-06-15 00:00:00

  • Measurement in clinical trials: a neglected issue for statisticians?

    abstract::Biostatisticians have frequently uncritically accepted the measurements provided by their medical colleagues engaged in clinical research. Such measures often involve considerable loss of information. Particularly, unfortunate is the widespread use of the so-called 'responder analysis', which may involve not only a lo...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3603

    authors: Senn S,Julious S

    更新日期:2009-11-20 00:00:00

  • Sam Greenhouse's years at the Census Bureau and the UNRRA.

    abstract::Sam Greenhouse joined the Census Bureau as a clerk at an interesting time period for the agency. The first use of sampling in the decennial census occurred in 1940. There was a major expansion of the amount of data collected. The organization of the Census Bureau underwent radical changes, including the growth of the ...

    journal_title:Statistics in medicine

    pub_type: 传,历史文章,杂志文章

    doi:10.1002/sim.1627

    authors: Keller J,Clark CZ

    更新日期:2003-11-15 00:00:00

  • Designs for phase I trials in ordered groups.

    abstract::We propose a new design for dose finding for cytotoxic agents in two ordered groups of patients. By ordered groups, we mean that prior to the study there is clinical information that would indicate that for a given dose one group would be more susceptible to toxicities than patients in the other group. The designs are...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.7133

    authors: Conaway MR,Wages NA

    更新日期:2017-01-30 00:00:00

  • Competing approaches to analysis of failure times with competing risks.

    abstract::For the analysis of time to event data in contraceptive studies when individuals are subject to competing causes for discontinuation, some authors have recently advocated the use of the cumulative incidence rate as a more appropriate measure to summarize data than the complement of the Kaplan-Meier estimate of discont...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.1135

    authors: Farley TM,Ali MM,Slaymaker E

    更新日期:2001-12-15 00:00:00

  • Evidence-based medicine as Bayesian decision-making.

    abstract::We review two recent trends: the emergence of evidence-based medicine and the growing use of Bayesian statistics in medical applications. Evidence-based medicine requires an integrated assessment of the available evidence, and associated uncertainty, but there is also an emphasis on decision-making, for individual pat...

    journal_title:Statistics in medicine

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0258(20001215)19:23<3291::aid-sim627>

    authors: Ashby D,Smith AF

    更新日期:2000-12-15 00:00:00

  • Nonparametric meta-analysis for diagnostic accuracy studies.

    abstract::Summarizing the information of many studies using a meta-analysis becomes more and more important, also in the field of diagnostic studies. The special challenge in meta-analysis of diagnostic accuracy studies is that in general sensitivity and specificity are co-primary endpoints. Across the studies both endpoints ar...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.6583

    authors: Zapf A,Hoyer A,Kramer K,Kuss O

    更新日期:2015-12-20 00:00:00

  • Cluster without fluster: The effect of correlated outcomes on inference in randomized clinical trials.

    abstract::Inference for randomized clinical trials is generally based on the assumption that outcomes are independently and identically distributed under the null hypothesis. In some trials, particularly in infectious disease, outcomes may be correlated. This may be known in advance (e.g. allowing randomization of family member...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.2977

    authors: Proschan M,Follmann D

    更新日期:2008-03-15 00:00:00

  • Prospective epidemiological studies involving paired organs.

    abstract::Standard methods for analysing survival data or case-control data normally concern factors affecting a subject as a whole. However, in a study of a condition that might develop in one or both of a pair of bodily organs information on response and on covariates may be available for each separately. This information can...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780070509

    authors: Whitehead J,Dorse C

    更新日期:1988-05-01 00:00:00

  • Smooth centile curves for skew and kurtotic data modelled using the Box-Cox power exponential distribution.

    abstract::The Box-Cox power exponential (BCPE) distribution, developed in this paper, provides a model for a dependent variable Y exhibiting both skewness and kurtosis (leptokurtosis or platykurtosis). The distribution is defined by a power transformation Y(nu) having a shifted and scaled (truncated) standard power exponential ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.1861

    authors: Rigby RA,Stasinopoulos DM

    更新日期:2004-10-15 00:00:00

  • A numerical strategy to evaluate performance of predictive scores via a copula-based approach.

    abstract::Assessing and comparing the performance of correlated predictive scores are of current interest in precision medicine. Given the limitations of available theoretical approaches for assessing and comparing the predictive accuracy, numerical methods are highly desired which, however, have not been systematically develop...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.8566

    authors: Zhang Y,Shao Y

    更新日期:2020-09-10 00:00:00

  • Descriptive statistical analyses of serial dilution data.

    abstract::The serial dilution assay (for example, an in vitro antimicrobic susceptibility test or a serum antibody titer assay) is an important technique in biomedical research. The structure of the experiment forces grouping of the threshold concentrations into intervals. Statistical methods to analyse threshold concentrations...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780070410

    authors: Hamilton MA,Rinaldi MG

    更新日期:1988-04-01 00:00:00

  • Sample sizes for phase II and phase III clinical trials: an integrated approach.

    abstract::In this paper the following problem of clinical research is explored. Several potential new treatments are available for use against a certain disease. These are evaluated in a series of pilot studies which will constitute phase II clinical trials. The most promising will then be compared with a standard treatment in ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780050510

    authors: Whitehead J

    更新日期:1986-09-01 00:00:00